BOEHRINGER INGELHEIM ANIMAL HEALTH USA

Get the most proven treatment available to control the clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses with PRASCEND. 1 PRASCEND has not been evaluated in breeding, pregnant or lactating horses. Adverse reactions may occur if animals other than horses ingest PRASCEND tablets... PRASCEND tablets are rectangular, light-red, half-scored tablets containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only. It's used for the control of clinical signs associated with PPID in horses. PRASCEND tablets should not be crushed due to the potential for increased human exposure... Preserved and protected in foil blister packs, the single-scored tablets make it simple to adjust dosage. Administer orally at a starting dose of 2 mcg/kg once daily. Dosage may be adjusted to effect, not to exceed 4 mcg/kg daily. PRASCEND tablets should not be crushed due to the potential for increased human exposure and care should be..

Also known as: Boehringer Ingelheim Animal Health USA Inc